[Antimicrobial activity of core-sheath surgical sutures modified with poly-3-hydroxybutyrate].

To impart antimicrobial activity to surgical sutures, weaved polyester fibers are coated with poly-3-hydroxybutyrate (PHB), containing the antimicrobial agent furazolidone (FZ). The prolonged FZ effect (7-14 days) is achieved by two-step application of a sheath, constituting 10% of the suture weight and containing 2-6% FZ. The sheath structure and antimicrobial activity of sutures can be modified by the introduction of other biocompatible and biodegradable polymers.

[Preparation of biodegradable porous films for use as wound coverings].

We studied the preparation of polymeric films formed from solutions of poly-3-hydroxybutyrate and poly-epsilon-caprolactone in chloroform and methylene chloride. A morphological study of film chips (electron microscopy) showed that solvent evaporation results in the formation of a heterogeneous structure with interpenetrating pores (1-20 microm). We proposed a new method for introducing the proteolytic enzyme and the aminopolysaccharide chitosan into the composition of polyester films.

[Production and properties of polymer composition containing lysozyme and protease C].

Conditions of the obtaining polymer compositions, containing protease C, lysozyme and polysacharide sodium alginate and their properties were developed and investigated. The effect of compositions content on properties of immobilized enzymes were demonstrated.

[Hydrolysis of chitosan sulfate by an enzyme complex from Streptomyces kurssanovii].

The possibility of enzymatic hydrolysis of chitosan was shown. The optimum conditions for the process are: sodium acetate buffer pH 6.0, 37 degrees C, 24 h, and the chitosan sulfate-protein volume ratio of 500:1 in the enzyme preparation.

Comparison of antithrombin activity of the polysulphate chitosan derivatives in in vivo and in vitro system.

In order to choose the proper method for evaluating the antithrombin activity in samples of chitosan polysulphate (CP) with different polymerization degrees and sulphation degrees, we estimated the ability of direct anticoagulants to depress the coagulability of recalcified sheep blood using the third international heparin standard (A1 - in vitro system) and determined such activity on pharmacodynamic curve (A2 - in vivo system). The curve admits the kinetics of CP elimination to be nonlinear in case of intravenous injection to rabbits, as it is observed in heparin: Ct = C(o)exp(-K(e)lt), where Ct is the CP concentration at the time moment t; C(o) is the CP concentration at the injection moment; Kel is the elimination constant. Besides, it is assumed that there is a linear approximation of the anticoagulant effect on the dose, which finally makes it possible to calculate the specific activity A2: T = KTCt+T(in), where T is the time of clot formation at different time intervals after CP injection; T(in) is the time of clot formation prior to CP injection.